Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
First CRISPR editing trial results assuage safety concerns
Nature Medicine》基因编辑工具增加致癌隐患- 生物通
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
CRISPR: gene editing is just the beginning : Nature News & Comment
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
Is Crispr the Next Antibiotic? - The New York Times
CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019
Untangling the CRISPR cancer scare
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
CRISPR, the disruptor : Nature News & Comment
CRISPR-Cas 9 corrects genetic defects in mice
CRISPR, the disruptor : Nature News & Comment
CRISPR gene editing - Wikipedia
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
